Convelo Therapeutics
PrivateLast Round
Series B
Dec 8, 2022
Total Funding Raised
$34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Convelo Therapeutics operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Series B round in December 2022.
Convelo Therapeutics is a biotechnology company developing a new class of medicines that unlock the regenerative capacity of the central nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convelo Therapeutics Comparables
Compare Convelo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Progentos Therapeutics | 92% | |
| Rewind Therapeutics | 92% | |
| Pheno Therapeutics | 90% |
For institutional investors. Book with your work email.
Convelo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 8, 2022 | ||||
| Series A | Jul 25, 2018 | ||||
| Seed | Dec 5, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Convelo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart | Series B |
| JumpStart Inc. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 257% MoM.
- May 18, 2026
Monthly visitors increased 372% MoM.
For institutional investors. Book with your work email.
Convelo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Convelo Therapeutics's valuation, stock price, and market status.
Is Convelo Therapeutics a public or private company?
Convelo Therapeutics is a private company.
What is the current stock price of Convelo Therapeutics?
Convelo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Convelo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Convelo Therapeutics worth (valuation)?
Valuation information for Convelo Therapeutics is not publicly available.
Can I buy Convelo Therapeutics stock?
Convelo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Convelo Therapeutics's last funding round?
Convelo Therapeutics's most recent funding round was Series B on December 8, 2022.
Who are the main investors in Convelo Therapeutics?
Key investors in Convelo Therapeutics include JumpStart, JumpStart Inc..
Will Convelo Therapeutics IPO soon?
No public IPO plans have been announced for Convelo Therapeutics.
How can I track Convelo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Convelo Therapeutics's shares on secondary markets.